Skip to main content
Michael Curi, MD, Vascular Surgery, Jersey City, NJ, Trinitas Regional Medical Center

MichaelA.CuriMDMPA

Vascular Surgery Jersey City, NJ

Chief, Vascular Surgery Rutgers-New Jersey Medical School

Dr. Curi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Curi's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Vascular Surgery, 2005 - 2006
  • University of Chicago
    University of ChicagoResidency, Surgery, 1998 - 2005
  • Rutgers New Jersey Medical School
    Rutgers New Jersey Medical SchoolClass of 1998

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2010 - 2025
  • FL State Medical License
    FL State Medical License 2018 - 2020
  • MD State Medical License
    MD State Medical License 2006 - 2010
  • IL State Medical License
    IL State Medical License 1998 - 2005
  • American Board of Surgery Vascular Surgery

Awards, Honors, & Recognition

  • Fellow American College of Surgeons

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Basilic Vein Superficialization Is an Effective Alternative to Transposition in Patients Requiring Brachiobasilic Arteriovenous Fistula  
    Joe T Huang, Frank T Padberg, Michael A Curi, Journal of Vascular Surgery

Authored Content

  • Basilic Vein Superficialization Is an Effective Alternative to Transposition in Patients Requiring Brachiobasilic Arteriovenous FistulaJuly 2018

Press Mentions

  • Humacyte Highlights Robust Expanded Access Program and Patient Testimonial for Human Acellular Vessels
    Humacyte Highlights Robust Expanded Access Program and Patient Testimonial for Human Acellular VesselsAugust 19th, 2021
  • Humacyte Launches Phase II Vascular Trauma Humacyl Vessel Trial
    Humacyte Launches Phase II Vascular Trauma Humacyl Vessel TrialOctober 26th, 2018
  • Humacyte Commences Phase II Vascular Trauma Trial
    Humacyte Commences Phase II Vascular Trauma TrialOctober 26th, 2018

Professional Memberships

Hospital Affiliations